Results 91 to 100 of about 81,484 (272)

Clinical and evolutive features of gouty arthritis

open access: yes, 2022
Introduction. Gout is a disease that may be associated with different comorbidities, which causes difficulties in their management and appreciation of clinical manifestations.
Codreanu, C.   +9 more
core   +1 more source

Living Microbial Drugs

open access: yesChemistry – A European Journal, EarlyView.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik   +3 more
wiley   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang   +7 more
wiley   +1 more source

The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout

open access: yesFrontiers in Pharmacology
BackgroundInterleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. Extensive research has confirmed the pathological roles of the IL-6/JAK2/STAT1/3 signaling pathway in inflammation, autoimmunity ...
Zeng Zhang   +27 more
doaj   +1 more source

New and improved strategies for the treatment of gout

open access: yes, 2010
Natalie Dubchak, Gerald F FalascaDivision of Rheumatology, Cooper University Hospital, UMDNJ – Robert Wood Johnson Medical School at Camden, Camden, NJ, USAAbstract: The Western world appears to be in the midst of the third great gout epidemic ...
null Natalie Dubchak   +3 more
core   +1 more source

Revisiting the Ethics of Urate‐Lowering Therapy Clinical Trials for Gout Management

open access: yes
Arthritis &Rheumatology, EarlyView.
Lisa K. Stamp, Dien Ho, Nicola Dalbeth
wiley   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen   +4 more
wiley   +1 more source

Diet in hyperurykemia and gout – myths and facts [PDF]

open access: yes, 2014
The influence of dietary habits on the gout development has been described for over a hundred years, but at present many opinions are being verified, which have not been so far supported by epidemiological or clinical studies.
Mariusz J. Puszczewicz   +1 more
core   +1 more source

Association of urine autoantibodies with disease activity in systemic lupus erythematosus

open access: yesFrontiers in Medicine
ObjectiveThe presence of urinary autoantibodies in patients with systemic lupus erythematosus (SLE) has been confirmed by several studies; however, the significance of their presence in urine remains unclear.
Yuxian Zhang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy